Prevention of cardio-reno-metabolic syndrome in 2025

Abstract

Background. Cardiorenal-metabolic syndrome is the description of the health disorder attributable to the interconnection between obesity, diabetes, chronic kidney disease and cardiovascular diseases (CHD, AF, stroke, peripheral vascular disease). The goal for 2025 is that CVD and risk factors are aggressively addressed. Objective(s). of the study: To review and analyze the current literature regarding the cardiorenal-metabolic syndrome to provide insights into prevention and management strategies for these patients. Materials and methods. A systematic literature review was conducted using databases such as: Medline, PubMed, Scopus, and Web of Science. The search was conducted by reviewing articles that where focused on "cardiovascular heart disease", "diabetes mellitus", “obesity”, “chronic heart failure”, „risk factors”, and “chronic kidney disease”. Results. Cardio - reno - metabolic diseases represent an unprecedented challenge to healthcare systems and providers worldwide. These disorders are grouped as multiple longterm conditions that span traditional medical specialties. There is an unmet need for greater clinical awareness, coupled with more effective interdisciplinary collaboration (cardiologist, nephrologist, endocrinologist and physician). There is general acceptance that the treatment of cardio - reno - metabolic syndrome should involve a holistic approach to prevention, screening, and management to improve outcomes and reduce long-term morbidity and mortality. Conclusion(s). Direct analysis of risk factors that may contribute to the onset and evolution of this syndrome, as well as targeted management for individuals at high risk of cardiovascular disease, will provide additional opportunities for improvement in the prevention, control, and treatment of these patients.